After assembly in the endoplasmic reticulum, MHC class II molecules are targeted to endosomal/lysosomal compartments for peptide loading. Antigenic peptides bind to MHC class II molecules in the MIIC, an acidic compartment resembling a mature endosome or prelysosome. Using LysoTracker Red to mark acidic organelles such as late endosomes and

lysosomes, these compartments were detected in both LAMP-2-deficient DB.DR4 and wild-type Frev cells (Fig. 3b). While the majority of MHC class II molecules localized to the cell surface in both DB.DR4 and Frev, greater co-localization of intracellular class II proteins in the LysoTracker Red+ compartments was observed in the LAMP-2-deficient DB.DR4 cells compared with Frev (Fig. 3b). These findings suggest a potential www.selleckchem.com/products/Nolvadex.html difference in the intracellular distribution of class II molecules in the absence of LAMP-2. We detected MHC class II in late endosomes/lysosomes in both DB.DR4 or Frev cells as measured by LAMP-1 staining (Fig. 3c); yet there appeared to be slightly more class II in larger LAMP-1+ vesicles in DB.DR4 cells. In wild-type Frev cells, intracellular class II was co-localized with LAMP-2 as well as LAMP-1 (data not shown). MHC class II molecules were not abundant in early endosomes in either wild-type or

LAMP-2-deficient cells as detected by staining for co-localization with the early endosome antigen, EEA-1 (data not shown). These results suggest that in LAMP-2-deficient cells, a greater number of MHC class II molecules may transit through or be retained in a mature endosome or lysosome-like compartment compared with wild-type B

cells. selleck chemicals Biochemical analysis of MHC class II ligands from human B-LCL revealed the presentation of epitopes from endogenous membrane antigens as well as exogenous protein antigens.37 Presentation of these endogenous antigens requires proteolytic processing to yield peptides that efficiently bind to MHC class II molecules within the endosomal/lysosomal compartments of APC. The presence of HLA-DRαβ dimers at the cell surface of Danon B-LCL suggested these class II molecules may acquire peptides Montelukast Sodium from a source other than exogenous antigen. The ability of the LAMP-2-deficient DB.DR4 to present antigenic peptides derived from an endogenous transmembrane protein was evaluated using an HLA-DR4-restricted T-cell hybridoma that recognizes an epitope from MHC class I HLA-A alleles.26 DB.DR4 cells were capable of efficiently activating the HLA-A-specific T cells to an extent slightly greater than the wild-type 7C3.DR4 cells (Fig. 4). A murine B cell CH27 transfected with HLA-DR4 (CH27.DR4) was only recognized by the HLA-A-specific T cells when pulsed with the HLA-A52–70 peptide before the addition of T cells (Fig. 4), confirming the specificity of these T cells for the HLA-A epitope. These results suggest that while MHC class II-restricted exogenous antigen presentation was impaired in the absence of LAMP-2 in the DB.